The Rise of Population-scale Genomic Projects for Pharma R&D Investments

With the announced $400 million investment from global investors including the Irish sovereign fund, Genuity Science (formerly WuXi NextCODE) announced that GMI would whole genome sequence and collect detailed medical data covering 60 major diseases, partnering with life sciences companies to analyze the data for insights. Read more here.